Search for: "IPR Pharmaceuticals, Inc."
Results 81 - 100
of 182
Sort by Relevance
|
Sort by Date
28 Sep 2016, 8:39 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
18 Sep 2016, 6:03 pm
Teva Pharmaceuticals USA, Inc., et al. [read post]
9 Sep 2016, 4:15 am
The IPRs, which were filed by American pharmaceutical developer Mylan Inc. [read post]
5 Sep 2016, 6:46 pm
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
16 Aug 2016, 5:15 pm
Teleflex Inc., 550 U.S.398 (2007), and cases from this court. [read post]
16 Aug 2016, 1:38 pm
She was a financial accountant for IPR Pharmaceuticals, Inc. at Astrazeneca P.L.C. where she was in charge of the preparation and filing of corporate tax forms, analysis of monthly income tax computation, set up pricing commerce reports, preparation of account’s reconciliations, journal cash postings and accounts receivable statements. [read post]
27 Jul 2016, 9:18 pm
Biomarin Pharmaceutical, Inc. [read post]
28 Jun 2016, 6:41 am
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Exhaustion: Impression Products, Inc. v. [read post]
3 Jun 2016, 6:40 am
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Exhaustion: Impression Products, Inc. v. [read post]
18 May 2016, 8:19 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
3 May 2016, 1:42 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
18 Apr 2016, 9:58 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
1 Apr 2016, 8:22 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
17 Mar 2016, 2:45 am
Lee, No. 15-446 (BRI construction in IPRs; institution decisions unreviewable) 2. [read post]
14 Mar 2016, 3:23 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
4 Mar 2016, 12:25 pm
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
26 Feb 2016, 9:17 am
Hazeltine Research, Inc., 339 U.S. 827, 836 (1950) (“The general rule is that the licensee under a patent license agreement may not challenge the validity of the licensed patent in a suit for royalties due under the contract. [read post]
17 Feb 2016, 9:20 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
3 Feb 2016, 8:57 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
26 Jan 2016, 11:23 am
The pharma industry is right to worry about IPRs. [read post]
